{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:35:59Z","timestamp":1763829359137,"version":"3.30.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":316,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.idcr.2024.e02118","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T09:11:55Z","timestamp":1731489115000},"page":"e02118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Antiviral combination treatment of SARS-CoV-2 after repeated treatment failures of remdesivir monotherapy: A case report"],"prefix":"10.1016","volume":"38","author":[{"given":"Anne Cathrine","family":"Bay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit Thorup","family":"R\u00f8ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas V.","family":"Sydenham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kat","family":"Steinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rune Micha","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line L.","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone W.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idcr.2024.e02118_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s12879-021-06429-5","article-title":"Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report","volume":"21","author":"Niyonkuru","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02118_bib2","unstructured":"WHO. World Health Organization. Therapeutics and COVID-19: living guideline; 2023. [Available from: \u3008https:\/\/iris.who.int\/bitstream\/handle\/10665\/373975\/WHO-2019-nCoV-therapeutics-2023.2-eng.pdf?sequence=1\u3009."},{"issue":"7898","key":"10.1016\/j.idcr.2024.e02118_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.idcr.2024.e02118_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/2159-8290.CD-21-1033","article-title":"Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies","volume":"12","author":"Lee","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.idcr.2024.e02118_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad181","article-title":"Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients","author":"Mikulska","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02118_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijid.2020.12.050","article-title":"Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir","volume":"104","author":"Camprub\u00ed","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2024.e02118_bib7","first-page":"765","article-title":"Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T","volume":"117","author":"Ambati","year":"2023","journal-title":"Int J Hematol"},{"key":"10.1016\/j.idcr.2024.e02118_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105247","article-title":"Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: a GISAID exploratory analysis","volume":"198","author":"Focosi","year":"2022","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.idcr.2024.e02118_bib9","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool","volume":"7","author":"O'Toole","year":"2021","journal-title":"Virus Evol"},{"issue":"67","key":"10.1016\/j.idcr.2024.e02118_bib10","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.21105\/joss.03773","article-title":"Nextclade: clade assignment, mutation calling and quality control for viral genomes","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.idcr.2024.e02118_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-1-4939-3578-9_16","article-title":"Visualizing genomic data using gviz and bioconductor","volume":"1418","author":"Hahne","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.idcr.2024.e02118_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41592-019-0430-y","article-title":"trackViewer: a bioconductor package for interactive and integrative visualization of multi-omics data","volume":"16","author":"Ou","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.idcr.2024.e02118_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144792","article-title":"Overwhelming mutations or SNPs of SARS-CoV-2: a point of caution","volume":"752","author":"Vankadari","year":"2020","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.idcr.2024.e02118_bib14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(21)00469-2","article-title":"Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial","volume":"22","author":"Kumar","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02118_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijid.2023.04.412","article-title":"Combination regimen of nirmatrelvir\/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: a case report and a scoping review of the literature","volume":"133","author":"Marangoni","year":"2023","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2024.e02118_bib16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/cid\/ciac847","article-title":"Dual antiviral therapy for persistent coronavirus disease 2019 and associated organizing pneumonia in an immunocompromised host","volume":"76","author":"Trottier","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idcr.2024.e02118_bib17","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/jac\/dkad159","article-title":"Triple antiviral treatment for COVID-19 in an immunocompromised patient","volume":"78","author":"Dentone","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.idcr.2024.e02118_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10071475","article-title":"The combination of molnupiravir with nirmatrelvir or GC376 has a synergic role in the inhibition of SARS-CoV-2 replication in vitro","volume":"10","author":"Gidari","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.idcr.2024.e02118_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1072202","article-title":"Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters","volume":"13","author":"Abdelnabi","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.idcr.2024.e02118_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00353-0","article-title":"Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation study","author":"Choi","year":"2024","journal-title":"Lancet Infect Dis"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092400194X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092400194X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T13:06:41Z","timestamp":1733404001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221425092400194X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":20,"alternative-id":["S221425092400194X"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02118","relation":{},"ISSN":["2214-2509"],"issn-type":[{"type":"print","value":"2214-2509"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral combination treatment of SARS-CoV-2 after repeated treatment failures of remdesivir monotherapy: A case report","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02118"}}